Difficult to obtain antibody drugs are now available as research consumables
Proleukin® the reference Aldesleukin cytokine drug
→
Divided into tubes
→
Aldesleukin Drug Aliquots
Aliquots of the reference drug Aldesleukin are now available as research consumables.
Aldesleukin drug aliquots can be used for in vitro or in vivo experiments. For biosimilar development, different batches of Aldesleukin drug can be ordered at the same time. Several other reference drug batches will become available soon.
The drug aliquots are generated by aliquoting (dividing and repackaging) the EU-licensed reference drug. Are you thinking why buy aliquots?
Easy Access
Easy to order as license-free research consumable
Multiple batches
Up to 10 batches of original drugs for examining batch-to-batch variations
Reduce costs
Up to 80% less compared to the original pharmaceutical price
Prompt delivery
Shipment within days worldwide according to GDP-standards
Documented origin
Information on batch, registration number, expiry date, GDP-compliant pedigree
What our clients say
Anjan Selz
Vice President
Head of Biosimilars EMEA
”Evidentic can supply different batches of reference products for precilinical research.The quick access to the on-stock batches allows for adhoc ordering, keeps costs down and makes a headstart possible!”
Thibault Jonckheere
CEO
“Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Tom H. Jin, M.D.
Director of Process Development
“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin
“Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics.”
Dr Stephan Schultz
Team Leader of Analytics/DSP
“Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization”
Aldesleukin / Proleukin
Product Reference
| Drug name | Proleukin® |
| INN | Aldesleukin |
| API type | Recombinant cytokine |
| Pharmacotherapeutic group | |
| ATC code | |
| Target of antibody | IL-2 R receptor |
| General function | |
| Short description | |
| Pharmacodynamic properties (Mechanism of action; Source EMA document) | |
| Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document) | |
| Original license holder | |
| Marketing authorisation numbers | |
| Marketing authorisation holder | |
| Name of the manufacturer of the biological active substance | |
| Name and address of the manufacturer(s) responsible for batch release | |
| Max shelf life | 24 months |
| Storage conditions | 2°C – 8°C |
| List of excipients | |